HOV vs. WST
Compare and contrast key facts about Hovnanian Enterprises, Inc. (HOV) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HOV or WST.
Correlation
The correlation between HOV and WST is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HOV vs. WST - Performance Comparison
Key characteristics
HOV:
-0.59
WST:
-0.76
HOV:
-0.61
WST:
-0.77
HOV:
0.93
WST:
0.85
HOV:
-0.39
WST:
-0.70
HOV:
-1.05
WST:
-1.78
HOV:
35.25%
WST:
23.26%
HOV:
63.03%
WST:
54.55%
HOV:
-99.70%
WST:
-59.29%
HOV:
-94.56%
WST:
-54.38%
Fundamentals
HOV:
$610.24M
WST:
$15.16B
HOV:
$32.46
WST:
$6.37
HOV:
3.16
WST:
33.12
HOV:
1.22
WST:
3.55
HOV:
0.20
WST:
5.23
HOV:
0.90
WST:
5.66
HOV:
$2.38B
WST:
$2.90B
HOV:
$448.26M
WST:
$1.00B
HOV:
$274.75M
WST:
$729.50M
Returns By Period
In the year-to-date period, HOV achieves a -25.64% return, which is significantly higher than WST's -34.82% return. Over the past 10 years, HOV has underperformed WST with an annualized return of 2.57%, while WST has yielded a comparatively higher 15.23% annualized return.
HOV
-25.64%
3.67%
-45.61%
-37.71%
52.22%
2.57%
WST
-34.82%
5.90%
-35.14%
-41.96%
1.53%
15.23%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HOV vs. WST — Risk-Adjusted Performance Rank
HOV
WST
HOV vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Hovnanian Enterprises, Inc. (HOV) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HOV vs. WST - Dividend Comparison
HOV has not paid dividends to shareholders, while WST's dividend yield for the trailing twelve months is around 0.39%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HOV Hovnanian Enterprises, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WST West Pharmaceutical Services, Inc. | 0.39% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
HOV vs. WST - Drawdown Comparison
The maximum HOV drawdown since its inception was -99.70%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for HOV and WST. For additional features, visit the drawdowns tool.
Volatility
HOV vs. WST - Volatility Comparison
Hovnanian Enterprises, Inc. (HOV) has a higher volatility of 20.06% compared to West Pharmaceutical Services, Inc. (WST) at 13.27%. This indicates that HOV's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HOV vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Hovnanian Enterprises, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HOV vs. WST - Profitability Comparison
HOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Hovnanian Enterprises, Inc. reported a gross profit of 106.50M and revenue of 673.62M. Therefore, the gross margin over that period was 15.8%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
HOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Hovnanian Enterprises, Inc. reported an operating income of 19.56M and revenue of 673.62M, resulting in an operating margin of 2.9%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
HOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Hovnanian Enterprises, Inc. reported a net income of 28.19M and revenue of 673.62M, resulting in a net margin of 4.2%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.